Trauma is every day here, says Kettering nurse deployed in Gaza
A nurse deployed in the Gaza Strip as part of the government's humanitarian response to the Israel-Gaza war described treating patients with "substantial" trauma. Mandy Blackman usually works at Kettering General Hospital in Northamptonshire, but is currently the nurse-in-charge of a field hospital in al-Mawasi run by the charity UK-Med. She said the hospital included "everyday things" such as GP services, an operating theatre and maternity care, but also dealt with emergency incidents."We have mass casualty incidents where we receive a number of patients in a very short space of time; not long ago we had about 34 people come in at 23:30 at night," she said.
"A lot of families were separated, so we had a lot of children here whose parents or surviving members of their family had gone to [another] hospital," Ms Blackman added. "We spent a good week trying to reunite families, so that was particularly pleasing after something so horrific had happened to them."This is her third deployment to the Gaza Strip and she said she felt "lucky" her employer allowed her to volunteer as "there is a need". "I am able to come and therefore I choose to come," she said. "I don't think you'd be human if you weren't affected by the cases that came in," she added."At home, yes, I do see trauma, but it's not on the same level that I see here, where it's pretty much every day."
Ms Blackman added that in al-Mawasi she was treating patients who had experienced significant weight loss. "There's evident malnutrition in children, so we do our best to get them on a targeted food programme."But it's also just trying to giving people some dignity while they are receiving the care here." The nurse has previously volunteered with UK-Med to care for patients with Ebola and diphtheria around the world. "My family have their concerns, because of what you see on the news," she said. "I have to reassure them that if something has happened that it isn't where we are. "I do everything I can to keep myself safe, and my family say they are proud of me, which is lovely."She said the field hospital in al-Mawasi was situated in a locked compound which was guarded and there were safe places for staff and patients to go if necessary. "People ask me 'does it make you cross when you come back [to England] and people are always demanding things?', but not really."Actually, we should all have the right to fresh water, healthcare and somewhere to live."It's trying to ensure people can access the healthcare they so desperately need," she said.
Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
15 hours ago
- The Independent
Critically ill patients with sepsis more likely to survive when given statins
Research indicates that critically ill sepsis patients who receive statins may have a higher chance of survival. A study of 6,000 sepsis patients given statins showed 14.3 per cent died within 28 days, compared to 23.4 per cent of 6,000 patients who did not receive statins, equating to a 39% reduced risk of death. The study, conducted using data from a hospital in Israel between 2008 and 2019, also found lower mortality rates in intensive care and overall hospital stays for statin users. Dr. Caifeng Li, the study's corresponding author, suggested that statins may offer a protective effect and improve outcomes for sepsis patients. Dr. Ron Daniels, founder and chief executive of the UK Sepsis Trust, supports calls for larger trials to confirm the findings, noting the potential survival benefit from the anti-inflammatory properties of statins.
The Independent
15 hours ago
- The Independent
This common prescription drug could reduce deaths by sepsis, study finds
Critically ill patients with sepsis who are given statins may be more likely to survive, new research suggests. Researchers set out to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4 per cent of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39 per cent reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4 per cent of statin patients died while in the intensive care unit compared with 13.6 per cent of those who did not receive statins. And during their overall hospital stay, some 11.5 per cent of sepsis patients who were given statins died, compared with 19.1 per cent of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39 per cent lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
BreakingNews.ie
15 hours ago
- BreakingNews.ie
Statins can reduce sepsis deaths, study suggests
People who are critically ill with sepsis may be more likely to survive if they are given statins, a new study suggests. Researchers wanted to explore whether the cholesterol-busting drugs may bring additional benefits for patients. Advertisement The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4 per cent of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39 per cent reduced risk of death within a month. Advertisement The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4 per cent of statin patients died while in the intensive care unit compared with 13.6 per cent of those who did not receive statins. And during their overall hospital stay, some 11.5 per cent of sepsis patients who were given statins died, compared with 19.1 per cent of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Advertisement Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In Ireland, about 12,000 people are affected by sepsis every year, according to the HSE. Sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. Advertisement But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39 per cent lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Advertisement Ireland Sepsis: Doctors launch awareness campaign about le... Read More Commenting on the study, Dr Ron Daniels, founder and chief executive of the Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
